Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.

den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.

Eur J Gen Pract. 2007;13(2):89-91.

PMID:
17534745
2.

Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases.

ten Berg MJ, Goettsch WG, van den Boom G, Smout AJ, Herings RM.

Eur J Gastroenterol Hepatol. 2006 May;18(5):475-81.

PMID:
16607141
3.

Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.

Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM.

Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):795-803.

PMID:
16178043
4.

Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD: results of the detection, intervention, and monitoring of COPD and asthma program.

Albers M, Schermer T, van den Boom G, Akkermans R, van Schayck C, van Herwaarden C, van Weel C.

Chest. 2004 Dec;126(6):1815-24.

PMID:
15596679
5.

Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study.

Goettsch WG, van den Boom G, Breekveldt-Postma NS, Smout AJ, Herings RM.

Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):803-10.

PMID:
15386693
6.

Secondary prevention after PCI: the cost-effectiveness of statin therapy in the Netherlands.

Chaplin S, Scuffham PA, Alon M, van den Boom G.

Neth Heart J. 2004 Aug;12(7-8):331-336.

7.

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study.

van Grunsven P, Schermer T, Akkermans R, Albers M, van den Boom G, van Schayck O, van Herwaarden C, van Weel C.

Respir Med. 2003 Dec;97(12):1303-12.

8.

Gender and adult undernutrition in developing countries.

Nubé M, Van Den Boom GJ.

Ann Hum Biol. 2003 Sep-Oct;30(5):520-37.

PMID:
12959894
9.

[Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ].

Groot MT, Ossenkoppele GJ, Kramer MH, van den Boom G, Huijgens PC, Uyl-de Groot CA.

Ned Tijdschr Geneeskd. 2003 Jul 26;147(30):1460-5. Dutch.

PMID:
12908349
10.

Food-consumption patterns in central West Africa, 1961 to 2000, and challenges to combating malnutrition.

Honfoga BG, van den Boom GJ.

Food Nutr Bull. 2003 Jun;24(2):167-82.

PMID:
12891821
11.

Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly.

Lundbäck B, Gulsvik A, Albers M, Bakke P, Rönmark E, van den Boom G, Brøgger J, Larsson LG, Welle I, van Weel C, Omenaas E.

Eur Respir J Suppl. 2003 May;40:3s-9s. Review.

12.

Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial.

Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP, Grol R, Van Weel C, Van Schayck CP.

Thorax. 2003 Jan;58(1):30-6.

13.

Randomized controlled economic evaluation of asthma self-management in primary health care.

Schermer TR, Thoonen BP, van den Boom G, Akkermans RP, Grol RP, Folgering HT, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2002 Oct 15;166(8):1062-72.

PMID:
12379549
14.

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

van den Boom G, Rutten-van Mölken MP, Molema J, Tirimanna PR, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2001 Dec 1;164(11):2057-66.

PMID:
11739135
15.

Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project.

van Schayck CP, van Der Heijden FM, van Den Boom G, Tirimanna PR, van Herwaarden CL.

Thorax. 2000 Jul;55(7):562-5.

16.

The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program.

van den Boom G, Rutten-van Mölken MP, Folgering H, van Weel C, van Schayck CP.

Prev Med. 2000 Apr;30(4):302-8.

PMID:
10731459
17.

[Role of spirometry in primary practice].

Schermer TR, Folgering HT, van den Boom G, Jacobs JE, van Weel C.

Ned Tijdschr Geneeskd. 1999 Nov 6;143(45):2246-51. Review. Dutch.

PMID:
10578423
18.

Volume calibration alone may be misleading.

van den Boom G, van der Star LM, Folgering H, van Schayck CP, van Weel C.

Respir Med. 1999 Sep;93(9):643-7.

19.

Present and future management of asthma and COPD: proceedings from WONCA 1998.

Thoonen BP, van Schayck CP, van Weel C, Levy ML, Spelman R, Price D, Ryan D, Bellamy D, van Grunsven P, Cloosterman S, van den Boom G, Gorgels W, Schönberger H.

Fam Pract. 1999 Jun;16(3):313-5.

PMID:
10439988
20.

Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.

van den Boom G, van Schayck CP, van Möllen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C.

Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8.

PMID:
9847260
21.

Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme.

van den Boom G, Rutten-van Mölken MP, Tirimanna PR, van Schayck CP, Folgering H, van Weel C.

Eur Respir J. 1998 Jan;11(1):67-72.

22.

Body mass index as indicator of standard of living in developing countries.

Nubé M, Asenso-Okyere WK, van den Boom GJ.

Eur J Clin Nutr. 1998 Feb;52(2):136-44.

PMID:
9505160
23.

Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977?

Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CL, van den Boom G, van Grunsven PM, van den Bosch WJ.

Br J Gen Pract. 1996 May;46(406):277-81.

24.

Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands.

Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ.

Scand J Gastroenterol. 1996 Jan;31(1):1-9.

PMID:
8927933
25.

The influence of an inhaled steroid on quality of life in patients with asthma or COPD.

van Schayck CP, Dompeling E, Rutten MP, Folgering H, van den Boom G, van Weel C.

Chest. 1995 May;107(5):1199-205.

PMID:
7750306

Supplemental Content

Loading ...
Support Center